Last reviewed · How we verify
NCT05699291: FLUOBREAST-2
Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.
trial testing Sentinel node detection technique in Sentinel Lymph Node in 163 participants. Completed in 17 May 2024.
17 May 2024
Quick facts
| Lead sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 163 |
| Start date | 23 February 2023 |
| Primary completion | 17 May 2024 |
| Estimated completion | 17 May 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Sentinel node detection technique
Conditions studied
- Sentinel Lymph Node — all drugs for Sentinel Lymph Node →
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →
Who can join
18 and older, female only, with Sentinel Lymph Node. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to analyze the average direct costs of each of these techniques, represented by the costs directly linked to the management of breast cancer, to the surgical intervention and to the techniques evaluated (Indocyanine Green and isotopes) which are: consultations, hospitalizations, resources consumed during the surgical intervention, as well as the time of the patients, transport...
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05699291
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sentinel Lymph Node
Currently open trials in the same condition.
- NCT07040657 — Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometria · NA · recruiting
- NCT07154563 — Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Ca · recruiting
- NCT06652672 — Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma · NA · recruiting
- NCT06713161 — Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Sta · recruiting
- NCT06259513 — Omission of Axillary Surgery in Breast Cancer Patients · NA · recruiting
Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials
Trials by the same sponsor.
- NCT07274657 — Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) · NA · not yet recruiting
- NCT07271277 — 3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study · NA · not yet recruiting
- NCT07263997 — Assessment of a New Traction Device in Submucosal Dissection of Colorectal Lesions · NA · not yet recruiting
- NCT07249645 — Description of Return to Sport in Amateur Athletes Who Underwent Several Functional Tests (K-STARTS, Vertical Jumps and · NA · not yet recruiting
- NCT06678646 — Ultrasound-guided Release of the Median Nerve at the Elbow in Patients With Lacertus Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05699291 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GCS Ramsay Santé pour l'Enseignement et la Recherche
- Last refreshed: 5 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05699291.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing